94 results
DEFA14A
EVOK
Evoke Pharma Inc
10 Apr 24
Additional proxy soliciting materials
3:35pm
to vote your shares. We encourage you to access and review all of the important information contained in the proxy materials before voting. Under … above available when you access the website and follow the instructions. SEE REVERSE FOR FULL AGENDA Copyright © 2024 BetaNXT, Inc. or its affiliates. All
424B3
EVOK
Evoke Pharma Inc
14 Mar 24
Prospectus supplement
6:44pm
commercial functions, for market access, marketing, distribution, and other related patient support services. If Eversana terminates the
agreement, our … for gastroparesis patients. With Gimoti being approved for the treatment of diabetic gastroparesis, patients and physicians now have access
8-K
EX-1.1
9a8ex6fhz59pra2wec
9 Feb 24
Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million
5:15pm
424B4
07aa1fim2hlf
9 Feb 24
Prospectus supplement with pricing info
5:14pm
8-K
EX-99.1
mjcvwqbba4blruf
15 May 23
Evoke Pharma Reports First Quarter 2023 Financial Results
4:23pm